BRIEF published on 03/02/2026 at 16:30, 3 months 14 days ago Sartorius Stedim Biotech: Share Capital and Voting Rights Update Share Capital Voting Rights French Commercial Code Sartorius Stedim Biotech EQS News Service
BRIEF published on 03/02/2026 at 16:30, 3 months 14 days ago Sartorius Stedim Biotech: Statement on Share Capital Share Capital Voting Rights Actions Sartorius Stedim Biotech AMF Regulations
PRESS RELEASE published on 03/02/2026 at 16:25, 3 months 14 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights in issued capital as of February 28, 2026 Voting Rights Capital Déclaration Shares Sartorius Stedim Biotech
PRESS RELEASE published on 02/16/2026 at 09:13, 4 months 1 day ago Sartorius Stedim Biotech releases Universal Registration Document 2025 Sartorius Stedim Biotech releases Universal Registration Document 2025, providing insights into its financial performance and strategic outlook for the future Financial Report Sartorius Stedim Biotech Annual Results Universal Registration Document Biopharma Industry
BRIEF published on 02/16/2026 at 09:13, 4 months 1 day ago Sartorius Stedim Biotech Releases 2025 Universal Registration Document Global Operations Sartorius Stedim Biotech Universal Registration Document Biopharmaceutical Solutions 2025 Financials
BRIEF published on 02/16/2026 at 09:13, 4 months 1 day ago Sartorius Stedim Biotech publishes its 2025 Universal Registration Document Consolidated Financial Statements Sartorius Stedim Biotech Universal Registration Document Fiscal Year 2025 2026 Objectives
PRESS RELEASE published on 02/16/2026 at 09:09, 4 months 1 day ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech releases Universal Registration Document 2025 with business development and financial statements. Leading biopharmaceutical partner based in Aubagne, France Financial Statements Business Development Sartorius Stedim Biotech Biopharmaceutical Industry Universal Registration Document
PRESS RELEASE published on 02/16/2026 at 09:08, 4 months 1 day ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech Group's Universal Registration Document 2025 now available at the provided link. Includes fiscal 2025 business development, 2026 forecast, and financial statements Financial Statements Investor Relations Sartorius Stedim Biotech Biopharmaceutical Industry Universal Registration Document 2025
BRIEF published on 02/06/2026 at 11:50, 4 months 11 days ago Sartorius Stedim Biotech proposes a dividend of €0.69 Financial Results Sartorius Stedim Biotech General Assembly Aubagne 2025 Dividend
BRIEF published on 02/06/2026 at 11:50, 4 months 11 days ago Sartorius Stedim Biotech Proposes Steady Dividend for 2025 Biotech Industry Dividend Proposal Sartorius Stedim Biotech Annual Shareholders' Meeting 2025 Financial Results
Published on 06/17/2026 at 14:00, 1 hour 24 minutes ago CHAR Tech Reminds Shareholders of June 18 Investor Update Call
Published on 06/17/2026 at 14:00, 1 hour 24 minutes ago Interpretation of High-Resolution Geophysics at Music Valley HREE Project
Published on 06/17/2026 at 14:00, 1 hour 24 minutes ago AEONIAN Completes Drilling at Jake Target and Advances District-Scale Copper-Silver Model, Koocanusa Project, BC
Published on 06/17/2026 at 15:16, 7 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 06/17/2026 at 15:15, 8 minutes ago Form 8.3 - The Vanguard Group, Inc.: Forward Industries Inc.
Published on 06/17/2026 at 08:45, 6 hours 39 minutes ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 3 hours ago Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 1 day 16 hours ago BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 1 day 20 hours ago Reporting on share buyback transactions carried out between June 8 and June 11, 2026
Published on 06/15/2026 at 18:32, 1 day 20 hours ago Edenred strengthens its electric charging offering with the acquisition of The Mobility House Solutions
